Treatment of adults with growth hormone (GH) deficiency with recombinant human GH

Journal of Clinical Endocrinology and Metabolism

Volumn 76, Issue 2, 1993, Pages 309-317

  Bengtsson, BengtÅke ^a   Edén, Staffan ^a   Lönn, Lars ^a   Kvist, Henry ^a   Stokland, Ann ^a   Lindstedt, Göran ^a   Bosaeus, Ingvar ^a   Tölli, Jukka ^a   Sjijstrijm, Lars ^a   Isaksson, Olle G P I ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; GROWTH HORMONE; HUMAN GROWTH HORMONE; LIOTHYRONINE; MAGNESIUM; OSTEOCALCIN; PARATHYROID HORMONE; PHOSPHATE; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; SOMATOMEDIN C; THYROXINE;

ADULT; ANKLE EDEMA; ARTHRALGIA; ARTICLE; BODY COMPOSITION; BONE METABOLISM; CARPAL TUNNEL SYNDROME; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DOUBLE BLIND PROCEDURE; FEMALE; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; HEART ATRIUM FIBRILLATION; HORMONE SUBSTITUTION; HUMAN; MALE; ONSET AGE; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; SUBCUTANEOUS DRUG ADMINISTRATION; THYROID HORMONE BLOOD LEVEL; TINNITUS;

ADIPOSE TISSUE; ADULT; BODY COMPOSITION; BODY WATER; CALCIUM; DOUBLE-BLIND METHOD; ELECTRIC IMPEDANCE; FEMALE; GROWTH HORMONE; HUMAN; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGE; MUSCLES; OSTEOCALCIN; PARATHYROID HORMONES; PHOSPHATES; PLACEBOS; POTASSIUM; PROCOLLAGEN; PSYCHOLOGICAL TESTS; RECOMBINANT PROTEINS; SUPPORT, NON-U.S. GOV'T; THYROXINE; TRIIODOTHYRONINE;

EID: 0027514167     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jcem.76.2.8432773     Document Type: Article

References (54)

1. Falkheden T. 1963 Patophysiological studies following hypophy-sectomy in man. PhD Thesis. Goteborg: University of Goteborg
2. Rosén T, Boaseus I, Tólli J, Lindstedt G, Bengtsson B-Á. Increased body fat mass and decreased extracellular fluid volume in adults with growth hormone deficiency. In Press.
3. Elgindy N, Grunditz R, Thorén M, Degerblad M, Sjóberg HE, Ringertz H. 1991 Long term follow-up of metacarpal cortical thickness and bone mineral density in panhypopituitarism. Radiol Diagn. 32:326-330.
4. Raben MS. 1962 Growth hormone. Clinical aspects. N Engl J Med. 266:82-86
5. Salomon F, Cuneo RC, Hesp R, Sónksen PH. 1989 The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med. 321:1797-1803.
6. Jorgensen JOL, Pedersen SA, Thuesen L, et al. 1989 Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet. 1:1221-1225
7. Merriam RG, Wachter KW. 1982 Algorithms for the study of episodic hormone secretion. Am J Physiol. 243:E310-E318.
8. Edén S, Bengtsson B-Á, Albertsson-Wikland K, et al. 1989 Plasma growth hormone profile in acromegaly before and ten days after transsphenoidal surgery. Acta Endocrinol (Copenh). 120:113-120.
9. Deleted in proof.
10. Bruce A, Andersson M, Arvidsson B, Isaksson B. 1980 Body composition of normal body potassium, body water, and body fat in adults on the basis of body height, body weight, and age. Scand J Clin Lab Invest. 40:461-473.
11. Kvist H, Sjóstróm L, Tylén U. 1986 Adipose tissue volume determinations in women by computed tomography: technical considerations. Int J Obesity. 10:53-67.
12. Kvist H, Chowdhury B, Grangárd U, Tylén U, Cederblad A. 1988 Adipose tissue volume determination in males by computed tomography, 40K. Int J Obesity 12:249-266.
13. Kvist H, Chowdury B, Grangárd U, Tylén U, Sjóstróm L. 1988 Predictive equations of total and visceral adipose tissue volumes derived from measurements with computed tomography in adult men and women. Am J Clin Nutr. 48:1351-1361.
14. Sjóstróm L, Kvist H, Cederblad A, Tylén U. 1986 Determination of total adipose tissue volume, body fat in women by computed tomography, 40K, and tritium. Am J Physiol. 250:E736-E745.
15. Sjóstróm L. 1991 A computed tomography based multicompartment body composition technique, anthropometric predictions of lean body mass and total and subcutaneous adipose tissue. Int] Obesity. 15:19-30.
16. Asberg M, Perris C, Schalling D, Sedvall G. 1978 The CPRS: development and application of a psychiatric rating scale. Acta Psychiatr Scand. (Suppl):271.
17. Derogatis LR, Cleary PA. 1977 Conformation of the dimensional structure of the SCL-90: a study in contrast validation. J Clin Psychol. 33:981-989.
18. Derogatis LR, Lipman RS, Covi L. 1973 The SCL-90: an outpatient psychiatric rating scale-preliminary report. Psychopharm Bull. 9:13-27.
19. Isaksson OGP, Jansson JO, Gause AM. 1982 Growth hormone stimulates longitudinal bone growth directly. Science. 216:1237-1239.
20. Goodman HM, Schwatrz J. 1974 Growth hormone and lipid metabolism. In: Knobil E, Sayer WH, eds. Handbook of physiology, vol 4, part 2. Washington DC: American Physiology Society; pp 211-232.
21. Zachman M, Fernandez F, Tassinari D, Thakker R, Prader A. 1989 Anthropometric measurements in patients with growth hormone deficiency before treatment with human growth hormone. EurJ Pediatr. 133:227-282.
22. Collip PJ, Curti V, Thomas J, Sharma RK, Maddaiah VT, Conn SH. 1973 Body composition changes in children receiving growth hormone. Metabolism. 22:589-595.
23. Bonnet F, Lodeweyckx MV, Eeckels R, Malvaux P. 1974 Subcutaneous adipose tissue and lipids in blood in growth hormone deficiency before and after treatment with human growth hormone. Pediatr Res. 8:800-805.
24. Parra A, Argote RM, Garcia G, Cervantes C, Alatorre S, Perez-Pasten E. 1979 Body composition in hypopituitary dwarfs before and during human growth hormone therapy. Metabolism. 28:851-857.
25. Fernandez A, Zachmann M, Prader A, Illig R. 1970 Isolated growth hormone deficiency in prepubertal children. Helv Paediatr Acta. 6:566-576.
26. Rosenbaum M, Gertner JM, Leibel R. 1989 Effects of systemic growth hormone (GH) administration on regional adipose tissue distribution and metabolism in GH-deficient children. J Clin Endocrinol Metab. 69:1274-1281.
27. Lapidus L, Bengtsson C, Larsson B, Pennert K, Rybo E, Sjôstrôm L. 1984 Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow-up of participants in the population study of women in Gothenburg Sweden. Br Med J. 289:1257-1261.
28. Rosén T, Bengtsson B-A. 1990 Premature cardiovascular mortality in hypopituitarism-a study of 333 consecutive patients. Lancet. 336:285-288.
29. Whitney JE, Bennet LL, Li CH. 1952 Reduction of urinary sodium and potassium produced by hypophyseal growth hormone in normal female rats. Proc Soc Exp Biol Med. 79:584-587.
30. Biglier EG, Watlington CO, Forsham PH. 1961 Sodium retention with human growth hormone and its subfractions. J Clin Endocrinol Metab. 21:361-370.
31. Shimomura Y, Lee M, Oku J, Bray GA, Glick Z. 1982 Sodium potassium dependent ATP:as in hypophysectomized rats: response to growth hormone, triiodothyronine, and cortisone. Metabolism. 3:213-216.
32. Bengtsson B-Â, Brummer RJM, Edén S, Bosaeus I. 1989 Body composition in acromegaly. Clin Endocrinol (Oxf). 30:121-130.
33. Deray G, Reiu M, Devynék MA, et al. 1987 Evidence of an endogenous digitalis-like factor in the plasma of patients with acromegaly. N Engl J Med. 316:575-580.
34. Sato T, Suzuki Y, Taketani T, et al. 1977 Enhanced peripheral conversion of thyroxine to triiodothyronine during hGH therapy in GH deficient children. J Clin Endocrinol Metab. 45:324-329.
35. Rezvani I, DiGeorge AM, Dowshen SA, Bourdony CJ. 1981 Action of human growth hormone (hGH) on extrathyroidal conversion of thyroxine (T4) to triiodothyronine (T3) in children with hypothyroidism. Pediatr Res. 15:6-9.
36. Grunfeld C, Sherman BM, Cavalieri RR. 1988 The acute effects of human growth hormone administration on thyroid function in normal men. J Clin Endocrinol Metab. 67:1111-1114.
37. Jorgensen JOL, Pedersen SA, Laurberg P, Weeke J, Skakkebaek NE, Christiansen JS. 1989 Effects of growth hormone therapy on thyroid function of growth hormone-deficient adults with and without concomitant thyroxine-substituted central hypothyroidism. J Clin Endocrinol Metab. 69:1127-1132.
38. Lippe BM, Van Herle AJ, LaFranchi SH, Uller RP, Lavin N, Kaplan SA. 1975 Reversible hypothyroidism in growth hormone-deficient children treated with human growth hormone. J Clin Endocrinol Metab. 40:612-618.
39. Lindstedt G, Weijkum L, Lundberg PA, Albertsson-Wikland K. 1984 Serum procollagen-III as an indicator of therapeutic effect in children treated for somatotropin deficiency. Clin Chem. 30:1879-1880.
40. Lindstedt G, Weijkum L, Lundberg PA, Albertsson-Wikland K. 1986 Increase in serum osteocalcin concentration is a slow indicator of therapeutic effect in children treated for somatropin deficiency. Clin Chem. 32:1589.
41. Albertsson-Wikland K, Lindstedt G, Lundberg PA. 1984 Serum immunoreactive procollagen-III levels in children of short stature during growth hormone treatment [Abstract 111]. Proc of the 7th Int Congr of Endocrinology.
42. Tapanainen P, Risteli L, Knip M, Kààr M, Risteli J. 1988 Serum amonterminal propeptide of type III collagen: a potential predictor of the response to growth hormone therapy. J Clin Endocrinol Metab. 23:167-171.
43. Danne T, Grüters A, Schnabel K, et al. 1988 Long-term monitoring of treatment with recombinant human growth hormone by serial determination of type III procollagen related antigens in serum. Pediatr Res. 23:167-171.
44. Trivedi P, Hindmarsh P, Risteli L, Mowat AP, Brook CGD. 1989 Growth velocity, growth hormone therapy, and serum concentrations of the aminoterminal propeptide of type III procollagen. J Pediatr. 114:225-230.
45. Delmas PD, Chatelin P, Malaval L, Bone G. 1987 Serum bone gla-protein in growth hormone deficient children. J Bone Mineral Res. 1:133-138.
46. Sartorio A, Conti A, Guzzaloni G, Faglia G. 1991 Serum osteocalcin levels in patients with GH deficiency before and during GH treatment. Acta Paediatr Scand. 80:100-102.
47. Marcus R, Butterfield G, Holloway L, et al. 1990 Effects of short term administration of recombinant human growth hormone to elderly people. J Clin Endocrinol Metab. 70:519-527.
48. Joborn C, Hetta J, Plamér M, Âkerstrôm G, Ljunghall S. 1986 Psychiatric symptomatology in patients with hyperparathyroidism. UppsJMed Sci. 91:77-87.
49. Walker EA, Roy-Byrne PP, Kanton WJ, Li L, Amos D, Jiranek G. 1990 Psychiatric illness and irritable bowel syndrome: a comparison with inflammatory bowel disease. Am J Psychiatry. 147:1656-1661.
50. Denicoff KD, Joffe RT, Lakshmanan MC, Robbins J, Rubinow DR. 1990 Neuropsychiatrie manifestations of altered thyroid state. Am J Psychiatry. 147:94-99.
51. Bjôrk S, Jônsson B, Westphal O, Levin JE. 1989 Quality of life of adults with growth hormone deficiency: a controlled study. Acta Paediatr Scand. 343(Suppl):3-11.
52. McGaulley GA. 1989 Quality of life assessment before and after growth hormone treatment in adults with growth hormone deficiency. Acta Paediatr Scand. 356(Suppl):70-72.
53. Almqvist O, Thorén M, Sààf M, Eriksson O. 1986 Effects of growth hormone substitution on mental performance in adults with growth hormone deficiency: a pilot study. Psychoneuroendocrinology. 3:347-352.